The Safety and Efficacy of Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibodies for the Preventive Treatment of Migraine: A Protocol for Multiple-Treatment Systematic Review and Meta-Analysis

Background: Migraine is a common and disabling primary headache disorder, associated with many medical comorbidities, highly prevalent, with complex treatment and management. Currently, monoclonal antibodies targeting the trigeminal sensory neuropeptide, calcitonin gene-related peptide (CGRP), are a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-Bravo-Rodrigo, Jaime, Pascual-Morena, Carlos, Flor-García, Amparo, Saz-Lara, Alicia, Sequí-Dominguez, Irene, Álvarez-Bueno, Celia, Barreda-Hernández, Dolores, Cavero-Redondo, Iván
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835448/
https://www.ncbi.nlm.nih.gov/pubmed/35162776
http://dx.doi.org/10.3390/ijerph19031753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835448/
https://www.ncbi.nlm.nih.gov/pubmed/35162776
http://dx.doi.org/10.3390/ijerph19031753

Ejemplares similares